{
    "clinical_study": {
        "@rank": "97365", 
        "arm_group": [
            {
                "arm_group_label": "Extracorporeal shock wave therapy 1", 
                "arm_group_type": "Active Comparator", 
                "description": "Extracorporeal shock wave therapy , (3000 shock waves/session of 0.2 mJ/mm2) for heel region and (400 shock waves/session of 0.2 mJ/mm2 per each trigger point) for gastrosoleus trigger points , 3 sessions at weekly intervals"
            }, 
            {
                "arm_group_label": "Extracorporeal shock wave therapy 2", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Extracorporeal shock wave therapy , (3000 shock waves/session of 0.2 mJ/mm2) for heel region  , 3 sessions at weekly intervals"
            }
        ], 
        "brief_summary": {
            "textblock": "Plantar fasciitis is one of the most common causes of heel pain. This study will be\n      performed in the purpose of determination the effects of extracorporeal shock wave therapy\n      of gastrosoleus trigger points in patients with plantar fasciitis"
        }, 
        "brief_title": "Effect of Extracorporeal Shock Wave Therapy of Gastrosoleus Trigger Points in Patients With Plantar Fasciitis", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Plantar Fasciitis", 
        "condition_browse": {
            "mesh_term": [
                "Fasciitis", 
                "Fasciitis, Plantar"
            ]
        }, 
        "detailed_description": {
            "textblock": "Plantar fasciitis is the most common cause of inferior heel pain, A great variety of\n      therapies have been reported for the treatment of plantar fasciitis including extracorporeal\n      shock wave therapy. Gastrosoleus muscle dysfunction is one of the most common contributing\n      factors to this disease .Despite the long history and the fact that this is a common\n      diagnosis made in clinical practice, the exact cause and best treatment for this condition\n      still are being explored. Although there is lack of high-quality studies demonstrating the\n      efficacy of extracorporeal shock wave therapy of gastrosoleus trigger points in patients\n      with plantar fasciitis , this study will be performed to examine the effect of\n      extracorporeal shock wave therapy of gastrosoleus trigger points in patients with plantar\n      fasciitis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. clinical diagnosis of plantar fasciitis\n\n          2. having at least one Gastrosoleus trigger point concomitantly.\n\n          3. having no response to conservative treatments for at least 3 months\n\n          4. willingness to participate\n\n        Exclusion Criteria:\n\n          1. Dysfunction of the knee or ankle\n\n          2. Neurologic abnormalities\n\n          3. Bleeding tendency (hereditary or acquired)\n\n          4. Nerve entrapment syndrome\n\n          5. A previous operation on the heel\n\n          6. Pregnancy\n\n          7. Evidences of Infection in lower limbs\n\n          8. A medical History of tumor\n\n          9. previous local corticosteroid  injection within 12 weeks"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "48", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01786057", 
            "org_study_id": "13914022"
        }, 
        "intervention": [
            {
                "arm_group_label": "Extracorporeal shock wave therapy 1", 
                "description": "Extracorporeal shock wave therapy , (3000 shock waves/session of 0.2 mJ/mm2) for heel region and (400 shock waves/session of 0.2 mJ/mm2 per each trigger point) for gastrosoleus trigger points , 3 sessions at weekly intervals", 
                "intervention_name": "Extracorporeal shock wave therapy 1", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Extracorporeal shock wave therapy 2", 
                "description": "Extracorporeal shock wave therapy , (3000 shock waves/session of 0.2 mJ/mm2) for heel region , 3 sessions at weekly intervals", 
                "intervention_name": "Extracorporeal shock wave therapy 2", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 5, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Isfahan", 
                    "country": "Iran, Islamic Republic of"
                }, 
                "name": "Department of Rehabilitation, Alzahra Hospital"
            }
        }, 
        "location_countries": {
            "country": "Iran, Islamic Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of Extracorporeal Shock Wave Therapy (ESWT)of Gastrosoleus Trigger Points in Patients With Plantar Fasciitis", 
        "overall_official": {
            "affiliation": "Isfahan University of Medical Sciences", 
            "last_name": "Farnaz Dehghan, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "Iran: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The pain score (100 mm Visual Analogue Score ) is evaluated before the first session and 4 weeks after the last session.", 
            "measure": "Change from baseline in pain severity after 3 weeks", 
            "safety_issue": "No", 
            "time_frame": "Up to 4 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01786057"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Isfahan University of Medical Sciences", 
            "investigator_full_name": "Farnaz Dehgan Hosseinabadi", 
            "investigator_title": "Dr.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "results_reference": [
            {
                "PMID": "16556754", 
                "citation": "Wang CJ, Wang FS, Yang KD, Weng LH, Ko JY. Long-term results of extracorporeal shockwave treatment for plantar fasciitis. Am J Sports Med. 2006 Apr;34(4):592-6."
            }, 
            {
                "PMID": "21255460", 
                "citation": "Cotchett MP, Landorf KB, Munteanu SE, Raspovic A. Effectiveness of trigger point dry needling for plantar heel pain: study protocol for a randomised controlled trial. J Foot Ankle Res. 2011 Jan 23;4:5. doi: 10.1186/1757-1146-4-5."
            }, 
            {
                "PMID": "22349369", 
                "citation": "Gleitz M, Hornig K. [Trigger points - Diagnosis and treatment concepts with special reference to extracorporeal shockwaves]. Orthopade. 2012 Feb;41(2):113-25. doi: 10.1007/s00132-011-1860-0. German."
            }, 
            {
                "PMID": "11991474", 
                "citation": "Ogden JA, Alvarez RG, Marlow M. Shockwave therapy for chronic proximal plantar fasciitis: a meta-analysis. Foot Ankle Int. 2002 Apr;23(4):301-8."
            }
        ], 
        "secondary_outcome": {
            "description": "The pain score (100 mm Visual Analogue Score ) and the modified criteria of the Roles and Maudsley score are evaluated at baseline and then 2 months after therapy.", 
            "measure": "Change from baseline in pain degree after 2 months.", 
            "safety_issue": "No", 
            "time_frame": "Up to 2 months"
        }, 
        "source": "Isfahan University of Medical Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Isfahan University of Medical Sciences", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}